CPA Welcomes FDA Proposal to Expose Hidden Foreign Suppliers in America’s Drug Supply Chain
For years, the most critical link in our drug supply chain — the upstream chemistry — has been invisible to our own regulators. A medicine finished in Europe is not necessarily a European medicine, and this rule finally begins to expose that fiction.
